Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Haematology

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.1999.01497.xPMID 10354161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal effects of amphotericin B lipid complex.

  1998cited by this paper
• An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

  1998cited by this paper
• Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

  1998cited by this paper
• Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

  1998cited by this paper
• Chronic hepatitis C virus and gastric MALT lymphoma.

  1998cited by this paper
• Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

  1998cited by this paper
• ANTIFUNGAL THERAPY IN ‘BONE MARROW FAILURE’

  1998cited by this paper
• A comparative analysis of lipid‐complexed and liposomal amphotericin B preparations in haematological oncology

  1998cited by this paper
• Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance.

  1998cited by this paper
• Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia

  1998cited by this paper
• Severe and common side-effects of amphotericin B lipid complex (Abelcet)

  1998cited by this paper
• Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

  1997cited by this paper
• Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis

  1997cited by this paper
• Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.

  1997cited by this paper
• Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

  1997cited by this paper
• EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

  1997cited by this paper
• Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses

  1997cited by this paper
• Lipid formulations of amphotericin B: recent progress and future directions.

  1996cited by this paper
• HCV and non-Hodgkin lymphoma.

  1996cited by this paper
• True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.

  1995cited by this paper
• Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single‐centre experience of 133 episodes in 116 patients

  1994cited by this paper
• The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.

  1994cited by this paper
• Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study

  1994cited by this paper
• Amphotericin B Lipid Complex (Ablc™): A Molecular Rationale for the Attenuation of Amphotericin B Related Toxicities

  1993cited by this paper
• Inherited WT1 mutation in Denys-Drash syndrome.

  1992cited by this paper
• Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

  1992cited by this paper
• Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre.

  1992cited by this paper
• Tissue Distribution of Amphotericin B Lipid Complex in Laboratory Animals *

  1991cited by this paper
• Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.

  1991cited by this paper
• Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.

  1990cited by this paper
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

  1990cited by this paper
• Lipid peroxidation inhibits norepinephrine-stimulated lipolysis in rat adipocytes. Reduction of beta-adreno-ceptor number.

  1988cited by this paper
• Iron deposition in the integument of lampreys

  1984cited by this paper
• Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.

  1979cited by this paper

• WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review)

  2016cites this paper
• Identification of genetic aberrations in myelodysplastic syndromes

  2012cites this paper
• Leptin and ghrelin serum concentrations in thalassemia major and intermedia patients and normal subjects

  2010cites this paper
• Evaluation of Leptin Levels in Major beta-Thalassemic Patients

  2009influential citation
• Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

  2008cites this paper
• Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.

  2008cites this paper
• Wilms' tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes

  2007cites this paper
• Primary Cutaneous Marginal Zone B-Cell Lymphoma of MALT Type in a Child

  2006cites this paper
• Role of the WT1 tumor suppressor in murine hematopoiesis.

  2003cites this paper
• WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

  2003cites this paper
• Hepatitis C and Lymphoma

  2002cites this paper
• B‐cell lymphomas involving the skin associated with hepatitis C virus infection

  2002cites this paper
• Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-thalassemia patients

  2002cites this paper
• Tumor suppressor genes in normal and malignant hematopoiesis

  2002cites this paper
• Relationship Between Leptin Levels and Body Indexes in Patients with Haematologic Malignancy.

  2001cites this paper
• Hepatitis C and lymphoma

  2000cites this paper